A subpopulation of the CD3+ peripheral T lymphocytes express the TCR-gamma/delta complex. Three distinct TCR-gamma forms that differ in size and in the ability to form a disulfide bridge with the TCR-delta subunit have been described. In this study we analyze the structural difference between the non-disulfide-linked 55-kD and 40-kD TCR-gamma chains. The 40-kD TCR-gamma form contains a smaller polypeptide backbone and carries less carbohydrate compared with the 55-kD TCR-gamma form. A cDNA clone corresponding to the 40-kD TCR-gamma subunit lacks one copy of the second exon of the constant region that is present in the other TCR-gamma subunit. This exon copy encodes part of the connector region that is located between the constant domain and the membrane spanning region. We show that the number of potential N-linked glycan attachment sites are the same for the two TCR-gamma forms. Since these attachment sites are located in the connector region we conclude that the connector region influences the amount of N-linked carbohydrates added to the core TCR-gamma polypeptide, probably by affecting the conformation of the protein. In contrast to the TCR-beta constant region usage, the TCR-gamma constant regions are unequally expressed. Virtually exclusive usage of disulfide-linked complexes were found in some individuals, while both the disulfide-linked and the 40-kD, non-disulfide-linked TCR-gamma forms were detected in other subjects. The ability to distinguish these TCR-gamma/delta forms now makes it possible to study the mechanisms that govern their selection and to determine if they correspond to functionally distinct isotypes.
Skip Nav Destination
Article navigation
1 August 1988
Article|
August 01 1988
Characterization of a third form of the human T cell receptor gamma/delta.
F Hochstenbach,
F Hochstenbach
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Search for other works by this author on:
C Parker,
C Parker
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Search for other works by this author on:
J McLean,
J McLean
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Search for other works by this author on:
V Gieselmann,
V Gieselmann
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Search for other works by this author on:
H Band,
H Band
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Search for other works by this author on:
I Bank,
I Bank
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Search for other works by this author on:
L Chess,
L Chess
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Search for other works by this author on:
H Spits,
H Spits
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Search for other works by this author on:
J L Strominger,
J L Strominger
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Search for other works by this author on:
J G Seidman
J G Seidman
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Search for other works by this author on:
F Hochstenbach
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
C Parker
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
J McLean
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
V Gieselmann
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
H Band
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
I Bank
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
L Chess
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
H Spits
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
J L Strominger
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
J G Seidman
Division of Tumor Virology, Dana-Faber Cancer Institute, Boston, Massachusetts.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1988) 168 (2): 761–776.
Citation
F Hochstenbach, C Parker, J McLean, V Gieselmann, H Band, I Bank, L Chess, H Spits, J L Strominger, J G Seidman; Characterization of a third form of the human T cell receptor gamma/delta.. J Exp Med 1 August 1988; 168 (2): 761–776. doi: https://doi.org/10.1084/jem.168.2.761
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement